SCHEMBL30847906

SCHEMBL30847906

Cn1nc(F)c2cccc(N)c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 2/20 0.47
▸ CRBN Q96SW2 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ TSHR P16473 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ MEN1 O00255 4/20 0.34
▸ USP2 O75604 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ KEAP1 Q14145 2/20 0.34
▸ ATM Q13315 1/20 0.34
▸ NFE2L2 Q16236 1/20 0.34
▸ MAPT P10636 4/20 0.34
▸ RGS12 O14924 2/20 0.34
▸ RECQL P46063 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19204861 0.79 ALDH1A1 (0.39) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL30029189 0.78 DDB1 (0.47) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL24754835 0.78 DDB1 (0.47) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL13106136 0.75 SSTR4 (0.44) PARP1
SCHEMBL30848080 0.75 DDB1 (0.45) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL29901540 0.72 GPR3 (0.44) DDB1CRBNALDH1A1HSD17B10CYP3A4
SCHEMBL19986782 0.72 GPR3 (0.44) DDB1CRBNALDH1A1HSD17B10CYP3A4
SCHEMBL9181361 0.70 SCN9A (0.42) DDB1CRBNALDH1A1HPGDHSD17B10
SCHEMBL30847980 0.70 JAK2 (0.30) —
SCHEMBL30848071 0.67 DDB1 (0.38) DDB1CRBNALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback